silybin has been researched along with Carcinoma, Basal Cell, Pigmented in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, C; Agarwal, R; Deep, G; Kant, R; Maurya, A; Orlicky, DJ; Paudel, S; Raina, B; Raina, K; Rigby, CM; Tiku, VR; You, Z | 1 |
Agarwal, C; Agarwal, R; Deep, G; Jain, A; Orlicky, DJ; Rigby, C | 1 |
Agarwal, C; Agarwal, R; Biedermann, D; Deep, G; Kren, V; Tilley, C; Valentová, K; Wempe, MF | 1 |
Agarwal, R; Deep, G; Tilley, C | 1 |
Agarwal, C; Agarwal, R; Deep, G; Dheeraj, A; O'Bryant, CL; Rigby, CM; Singh, RP | 1 |
1 review(s) available for silybin and Carcinoma, Basal Cell, Pigmented
Article | Year |
---|---|
Chemopreventive opportunities to control basal cell carcinoma: Current perspectives.
Topics: Animals; Antioxidants; Biological Products; Carcinoma, Basal Cell; Hedgehog Proteins; Humans; Silybin; Silymarin; Skin; Skin Neoplasms | 2015 |
4 other study(ies) available for silybin and Carcinoma, Basal Cell, Pigmented
Article | Year |
---|---|
Chemopreventive efficacy of silibinin against basal cell carcinoma growth and progression in UVB-irradiated Ptch+/- mice.
Topics: Animals; Carcinoma, Basal Cell; Female; Hedgehog Proteins; Male; Mice; Patched-1 Receptor; Silybin; Skin Neoplasms; Ultraviolet Rays | 2022 |
Silibinin inhibits ultraviolet B radiation-induced mast cells recruitment and bone morphogenetic protein 2 expression in the skin at early stages in Ptch(+/-) mouse model of basal cell carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Bone Morphogenetic Protein 2; Carcinoma, Basal Cell; Chemoprevention; Cyclin D1; Disease Models, Animal; DNA Damage; Mast Cells; Mice; Mice, Transgenic; Patched-1 Receptor; Signal Transduction; Silybin; Skin; Skin Neoplasms; Tumor Suppressor Proteins; Ultraviolet Rays | 2019 |
Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.
Topics: Allografts; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Basal Cell; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Enzyme Activation; Humans; Mice; Mice, Knockout; NF-kappa B; Signal Transduction; Silybin; Silymarin; Skin Neoplasms; Transcription Factor AP-1; Transcription Factors; Tumor Stem Cell Assay | 2016 |
Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Hedgehog Proteins; Humans; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Silybin; Skin Neoplasms | 2017 |